Jacobs Levy Equity Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,545
Closed -$3.68M 1007
2024
Q1
$3.68M Sell
30,545
-9,116
-23% -$1.1M 0.02% 484
2023
Q4
$4.88M Sell
39,661
-4,096
-9% -$504K 0.02% 428
2023
Q3
$5.66M Sell
43,757
-5,530
-11% -$716K 0.03% 353
2023
Q2
$6.11M Buy
49,287
+11,105
+29% +$1.38M 0.04% 356
2023
Q1
$5.59M Buy
+38,182
New +$5.59M 0.03% 373
2022
Q2
Sell
-171,187
Closed -$26.6M 1043
2022
Q1
$26.6M Sell
171,187
-1,319
-0.8% -$205K 0.18% 139
2021
Q4
$22M Buy
172,506
+122,761
+247% +$15.6M 0.15% 164
2021
Q3
$6.48M Sell
49,745
-166,850
-77% -$21.7M 0.04% 386
2021
Q2
$38.5M Sell
216,595
-8,598
-4% -$1.53M 0.26% 107
2021
Q1
$37M Buy
225,193
+27,119
+14% +$4.46M 0.29% 83
2020
Q4
$32.7M Buy
198,074
+13,541
+7% +$2.23M 0.29% 87
2020
Q3
$26.3M Sell
184,533
-29,728
-14% -$4.24M 0.27% 93
2020
Q2
$23.6M Buy
214,261
+94,644
+79% +$10.4M 0.26% 100
2020
Q1
$11.9M Sell
119,617
-29,358
-20% -$2.93M 0.15% 163
2019
Q4
$22.2M Sell
148,975
-16,011
-10% -$2.39M 0.22% 120
2019
Q3
$21.1M Buy
164,986
+13,642
+9% +$1.75M 0.26% 106
2019
Q2
$21.6M Buy
151,344
+32,040
+27% +$4.57M 0.3% 85
2019
Q1
$17.1M Buy
+119,304
New +$17.1M 0.25% 105
2016
Q4
Sell
-8,850
Closed -$1.08M 1012
2016
Q3
$1.08M Sell
8,850
-15,507
-64% -$1.88M 0.02% 564
2016
Q2
$3.44M Buy
+24,357
New +$3.44M 0.07% 319
2015
Q2
Sell
-7,678
Closed -$1.33M 830
2015
Q1
$1.33M Hold
7,678
0.02% 432
2014
Q4
$1.26M Sell
7,678
-10,450
-58% -$1.71M 0.02% 461
2014
Q3
$2.91M Buy
18,128
+1,723
+11% +$277K 0.05% 321
2014
Q2
$2.41M Sell
16,405
-1,643
-9% -$242K 0.04% 375
2014
Q1
$2.5M Buy
18,048
+16,158
+855% +$2.24M 0.04% 365
2013
Q4
$239K Sell
1,890
-9,000
-83% -$1.14M ﹤0.01% 847
2013
Q3
$1M Sell
10,890
-3,570
-25% -$328K 0.02% 532
2013
Q2
$994K Buy
+14,460
New +$994K 0.02% 574